Corcept Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $36.51, giving the company a market capitalization of 3.82B. It carries a P/E multiple of 42.69.
During the trading session on 2026-01-14, Corcept Therapeutics(CORT) shares reached a daily high of $36.70 and a low of $36.40. At a current price of $36.51, the stock is +0.3% higher than the low and still -0.5% under the high.
Trading volume for Corcept Therapeutics(CORT) stock has reached 1.38K, versus its average volume of 4.63M.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
CORT News
Advertisement What triggered the latest move in Corcept Therapeutics (CORT)? The recent swing in Corcept Therapeutics (CORT) shares traces back to an FDA Comp...
Key Points The chief development officer of Corcept Therapeutics sold 20,000 shares of the biotech for $703,656 on Tuesday. The transaction was executed as a...
Bearish flow noted in Corcept Therapeutics (CORT) with 1,232 puts trading, or 1.1x expected. Most active are Feb-26 30 puts and Feb-26 35 puts, with total volum...